VALNEVA (EPA:VLA) | WebDisclosure

PRESS RELEASE

published on 04/09/2025 at 07:00, 1 year 2 months ago

Valneva et LimmaTech annoncent la vaccination du premier participant à l’étude pédiatrique de Phase 2 du candidat vaccin tétravalent contre la shigellose S4V2
Valneva et LimmaTech annoncent la vaccination du premier participant à l’étude pédiatrique de Phase 2 du candidat vaccin tétravalent contre la shigellose S4V2

Valneva Vaccin Shigellose LimmaTech Étude Pédiatrique
PRESS RELEASE

published on 04/09/2025 at 07:00, 1 year 2 months ago

Valneva and LimmaTech Announce First Vaccination in Phase 2 Infant Study of Tetravalent Shigella Vaccine Candidate S4V2
Valneva and LimmaTech announce first vaccination in Phase 2 infant study of tetravalent Shigella vaccine candidate S4V2. Study aims to combat shigellosis, a deadly diarrheal disease

Valneva Phase 2 Study Shigella Vaccine Shigellosis LimmaTech
PRESS RELEASE

published on 03/20/2025 at 07:00, 1 year 3 months ago

Valneva publie ses résultats financiers 2024 et fait un point sur son activité et ses perspectives financières
PRESS RELEASE

published on 03/20/2025 at 07:00, 1 year 3 months ago

Valneva Reports Full Year 2024 Results and Provides Business Updates and Outlook
Valneva SE reports solid full year 2024 results exceeding growth targets. Financial outlook for 2025 includes strong revenue growth and strategic investments. Key milestones and financial information discussed

Financial Results Valneva 2025 Outlook Vaccine Company Clinical Progress
BRIEF

published on 02/05/2025 at 07:05, 1 year 4 months ago

Valneva Achieves UK Approval for World's First Chikungunya Vaccine

Public Health Valneva Chikungunya Vaccine UK Approval Travel Safety
BRIEF

published on 02/05/2025 at 07:05, 1 year 4 months ago

Valneva obtient l'approbation du Royaume-Uni pour le premier vaccin contre le chikungunya au monde

Valneva Santé Publique Vaccin Contre Le Chikungunya Approbation Du Royaume-Uni Sécurité En Voyage
PRESS RELEASE

published on 02/05/2025 at 07:00, 1 year 4 months ago

Valneva Receives Marketing Authorization in the UK for the World’s First Chikungunya Vaccine, IXCHIQ®
Valneva receives marketing authorization in the UK for the world's first chikungunya vaccine, IXCHIQ®. Single-dose vaccine for individuals 18+ provides rapid and strong immune response

UK Valneva MHRA Chikungunya Vaccine IXCHIQ®
BRIEF

published on 12/05/2024 at 07:35, 1 year 6 months ago

Valneva Reports Share and Voting Rights as of November 30, 2024

Euronext Paris Share Capital Voting Rights Valneva Double Voting
BRIEF

published on 12/05/2024 at 07:35, 1 year 6 months ago

Valneva publie ses actions et ses droits de vote au 30 novembre 2024

Euronext Paris Capital Social Droit De Vote Valneva Double Vote
PRESS RELEASE

published on 12/05/2024 at 07:30, 1 year 6 months ago

VALNEVA - Declaration of shares and voting rights: November 30, 2024
VALNEVA declares transfer of 1,000 shares into bearer form with double voting rights on November 26, 2024. Total voting rights: 178,371,727

Euronext Paris Voting Rights Shares Stock Market Valneva

Published on 06/23/2026 at 01:55, 2 hours 44 minutes ago

Ameriwest Launches Bornite Community and Stakeholder Engagement Program
Published on 06/22/2026 at 23:25, 5 hours 14 minutes ago

Infield Minerals Announces Intention to Issue Shares for Kings Canyon Gold Property Option Payment
Published on 06/22/2026 at 23:05, 5 hours 34 minutes ago

Gamma Resources Settles Remaining Balance of Outstanding Debt
Published on 06/22/2026 at 21:05, 7 hours 34 minutes ago

RUM Announces Voting Results From Annual General Meeting of Shareholders
Published on 06/22/2026 at 19:45, 8 hours 54 minutes ago

Trans Canada Gold Appoints Paradigm Drilling Ltd. for Drilling at the Harrison Lake District Scale Gold Project, Drilling to Commence Shortly

View all ACCESSWIRE

Published on 06/23/2026 at 04:05, 34 minutes ago

Aosom France x FFHandball: Enhancing the Fan Experience Through Home & Outdoor Living Solutions
Published on 06/23/2026 at 01:35, 3 hours 4 minutes ago

DoH and Sanofi Partner to Advance Vaccine Innovation
Published on 06/22/2026 at 21:07, 7 hours 32 minutes ago

EQS-Adhoc: RWE Aktiengesellschaft: RWE sets placement price for shares from capital measure and raises gross proceeds of 4 billion EUR
Published on 06/22/2026 at 20:50, 7 hours 49 minutes ago

Ethlabs, Founded by Former Ethereum Foundation Contributors and Funded by Bitmine, Sharplink and Joe Lubin, Launches to Accelerate Ethereum's Institutional Supercycle
Published on 06/22/2026 at 20:32, 8 hours 6 minutes ago

EQS-Adhoc: Deutsche Konsum Real Estate AG: Daniel Löhken appointed Chief Executive Officer of the Company and Dr Kai Gregor Klinger appointed new Chairman of the Supervisory Board

View all EQS

Published on 06/22/2026 at 18:45, 9 hours 54 minutes ago

Governance evolution
Published on 06/22/2026 at 18:45, 9 hours 54 minutes ago

ÉVOLUTION DE LA GOUVERNANCE
Published on 06/22/2026 at 18:16, 10 hours 22 minutes ago

ANTOINE FREY INCREASES HIS STAKE IN FREY
Published on 06/22/2026 at 18:16, 10 hours 22 minutes ago

ANTOINE FREY SE RENFORCE AU CAPITAL DE FREY
Published on 06/22/2026 at 18:00, 10 hours 39 minutes ago

GUILLEMOT CORPORATION : DECES DE M. CLAUDE GUILLEMOT, Président du Groupe GUILLEMOT CORPORATION

View all LES ECHOS COMFI WIRE

News